Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02081586 · ClinicalTrials.gov registry record · NA

mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT02081586: Completed NA study, sponsored by University of Pittsburgh.

NCT02081586 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02081586, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

This is a pilot study examining the clinical effects of a brief Cognitive Therapy phone approach augmented with a CBT smartphone app geared towards patients with type 2 diabetes patients in poor control.

Primary Outcome

Change from baseline HbA1c level to post intervention

Interventions

  • BEHAVIORAL CBT
  • DEVICE Smartphone app
  • OTHER Standard Diabetes Care at PCP

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2013-05
Est. Completion 2014-07
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT02081586 record still lists

NCT02081586 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which CBT is the first listed.

NCT02081586 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02081586 about?

NCT02081586 is a clinical study titled "mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot Study". This is a pilot study examining the clinical effects of a brief Cognitive Therapy phone approach augmented with a CBT smartphone app geared towards patients with type 2 diabetes patients in poor control.

What is the current status of trial NCT02081586?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-05. Estimated completion is 2014-07.

What interventions are being tested in trial NCT02081586?

The interventions under investigation include: CBT (BEHAVIORAL), Smartphone app (DEVICE), Standard Diabetes Care at PCP (OTHER).

Who is sponsoring clinical trial NCT02081586?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02081586's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02081586, the US trial registry maintained by the National Library of Medicine. NCT02081586 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.